KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for Opko Health (OPK) over the last 16 years, with Q3 2025 value amounting to $3.0 million.

  • Opko Health's Share-based Compensation rose 714.29% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year increase of 184.68%. This contributed to the annual value of $11.0 million for FY2024, which is 319.81% down from last year.
  • As of Q3 2025, Opko Health's Share-based Compensation stood at $3.0 million, which was up 714.29% from $2.2 million recorded in Q2 2025.
  • In the past 5 years, Opko Health's Share-based Compensation registered a high of $7.6 million during Q1 2022, and its lowest value of $2.2 million during Q2 2025.
  • For the 5-year period, Opko Health's Share-based Compensation averaged around $3.3 million, with its median value being $3.0 million (2025).
  • As far as peak fluctuations go, Opko Health's Share-based Compensation surged by 18775.97% in 2022, and later tumbled by 6432.98% in 2023.
  • Over the past 5 years, Opko Health's Share-based Compensation (Quarter) stood at $3.7 million in 2021, then dropped by 13.75% to $3.2 million in 2022, then dropped by 16.5% to $2.7 million in 2023, then increased by 14.29% to $3.0 million in 2024, then decreased by 1.57% to $3.0 million in 2025.
  • Its Share-based Compensation was $3.0 million in Q3 2025, compared to $2.2 million in Q2 2025 and $2.6 million in Q1 2025.